Browse by Glasgow Author (original) (raw)

Number of items: 15.

2018

Pellicano, F. et al. (2018)Hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood, 131(14), pp. 1532-1544. (doi: 10.1182/blood-2017-05-783845) (PMID:29437554) (PMCID:PMC6027092)

2015

Kranc, K. R. et al. (2015)Acute loss of Cited2 impairs Nanog expression and decreases self-renewal of mouse embryonic stem cells. Stem Cells, 33(3), pp. 699-712. (doi: 10.1002/stem.1889) (PMID:25377420)

2014

Gezer, Deniz, Vukovic, Milica, Soga, Tomoyoshi, Pollard, Patrick J. and Kranc, Kamil R.(2014)Concise review: genetic dissection of hypoxia signaling pathways in normal and leukemic stem cells. Stem Cells, 32(6), pp. 1390-1397. (doi: 10.1002/stem.1657)

2013

Guitart, A.V. et al. (2013)Hif-2 is not essential for cell-autonomous hematopoietic stem cell maintenance. Blood, 122(10), pp. 1741-1745. (doi: 10.1182/blood-2013-02-484923)

2012

Calaminus, Simon D.J., Guitart, Amelie V., Sinclair, Amy, Schachtner, Hannah, Watson, Steve P., Holyoake, Tessa L., Kranc, Kamil R. and Machesky, Laura M. ORCID: https://orcid.org/0000-0002-7592-9856(2012)Lineage tracing of Pf4-Cre marks hematopoietic stem cells and their progeny. PLoS ONE, 7(12), e51361. (doi: 10.1371/journal.pone.0051361) (PMID:23300543) (PMCID:PMC3531453)

2011

Mortensen, M. et al. (2011)The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. Journal of Experimental Medicine, 208(3), pp. 455-467. (doi: 10.1084/jem.20101145)

2010

Pollard, P.J. and Kranc, K.R.(2010)Hypoxia Signaling in Hematopoietic Stem Cells: A Double-Edged Sword. Cell Stem Cell, 7(3), pp. 276-278. (doi: 10.1016/j.stem.2010.08.006)

2009

Kranc, K.R, Schepers, H., Rodrigues, N.P., Bamforth, S., Villadsen, E., Ferry, H., Bouriez-Jones, T., Sigvardsson, M., Bhattacharya, S. and Jacobsen, S.E.(2009)Cited2 is an essential regulator of adult hematopoietic stem cells. Cell Stem Cell, 5(6), pp. 659-665. (doi: 10.1016/j.stem.2009.11.001)

Harkiolaki, M. et al. (2009)T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity, 30(3), pp. 348-357. (doi: 10.1016/j.immuni.2009.01.009)

2006

Gregersen, J.W., Kranc, K.R., Ke, X., Svendsen, P., Madsen, L.S., Thomsen, A.R., Cardon, L.R., Bell, J.I. and Fugger, L.(2006)Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature, 443, pp. 574-577. (doi: 10.1038/nature05133)

2005

Kranc, K., Taylor, A.M., Willcox, N. and Fugger, L.(2005)Control of autoimmunity by 'epitope theft'. Trends in Molecular Medicine, 11(1), pp. 1-4. (doi: 10.1016/j.molmed.2004.11.002)

2003

Kranc, K.R., Bamforth, S.D., Braganca, J., Norbury, C., van Lohuizen, M. and Bhattacharya, S.(2003)Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF. Molecular and Cellular Biology, 23(21), pp. 7658-7666. (doi: 10.1128/MCB.23.21.7658-7666.2003)

2001

Bamforth, S.D., Bragança, J., Eloranta, J.J., Murdoch, J.N., Marques, F.I.R., Kranc, K.R., Farza, H., Henderson, D.J., Hurst, H.C. and Bhattacharya, S.(2001)Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nature Genetics, 29(4), pp. 469-474. (doi: 10.1038/ng768)

Kranc, K.R., Pyne, G.J., Tao, L., Claridge, T.D.W., Harris, D.A., Cadoux-Hudson, T.A.D., Turnbull, J.J., Schofield, C.J. and Clark, J.F.(2001)Oxidative degradation of bilirubin produces vasoactive compounds. European Journal of Biochemistry, 267(24), pp. 7094-7101. (doi: 10.1046/j.1432-1327.2000.01812.x)

1999

Clark, J.F. and Kranc, K.R.(1999)The role of the mitochondrion in smooth muscle cell fate choices of proliferation versus apoptosis during vascular and cardiovascular diseases. Expert Opinion on Therapeutic Targets, 3(4), pp. 513-525. (doi: 10.1517/14728222.3.4.513)

This list was generated on Tue Feb 17 16:27:05 2026 GMT.